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Early reports on T cell antigen receptor (TCR) signaling uncovered a rapid increase in intra-
cellular calcium concentration and the activation of calcium-dependent protein kinase as
necessary forT cell activation. CytolyticT cell clones were instrumental in the discovery of
intracellular cytolytic granules, and the isolation of the perforin and granzyme molecules as
the molecular effectors of cell-mediated lysis of target cells via apoptosis. Cytolytic T cell
clones and TCR cDNA clones were also instrumental for the generation of TCR transgenic
animals, which provided definitive evidence for negative selection of self-reactive imma-
ture thymocytes. In addition, studies of TCR complex signaling of immature thymocytes
compared with mature T cells were consistent with the interpretation that negative selec-
tion occurs as a consequence of the incapacity of immature cells to produce IL-2, resulting
in cytokine deprivation apoptosis. By comparison, taking advantage of clonedTCRs derived
fromT cell clones reactive with male-specific molecules, usingTCR transgenic mice it was
possible to document positive selection of female thymocytes when the male-specific
molecules were absent. Focusing on the molecular mechanisms of T cell “help” for the
generation of antibody-forming cells following the path opened by the elucidation of the
IL-2 molecule, several groups were successful in the identification, isolation, and character-
ization of three new interleukin molecules (IL-4, IL-5, and IL-6) that promote the proliferation
and differentiation of B cells. In addition, the identification of a B cell surface molecule
(CD40) that augmented B cell antigen receptor-stimulated proliferation and differentiation
led to the discovery of a T cell activation surface molecule that proved to be the CD40-
ligand, thus finally providing a molecular explanation for “linked or cognate” recognition
whenT cells and B cells interact physically. Accordingly, the decade after the generation of
the firstT cell clones saw the elucidation of the molecular mechanisms ofT cell cytotoxicity
andT cell help, thereby expanding the number of molecules responsible for adaptiveT cell
immunity.
Keywords: adaptive immunity, TCR signaling, cell-mediated cytolysis, perforin, granzymes, IL-4-6, CD40, CD40-
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TCR SIGNALS
From the days of Nowell, T cell “activation” was synonymous with
mitogen/antigen stimulation that resulted in T cell proliferation
(1). Indeed, because tritiated thymidine (3H-TdR) incorporation
was generally used as the read-out for T cell activation, it was
assumed by everyone that the trigger for T cell proliferation resided
solely with activation of the T cell antigen receptor (TCR) complex.
However, with the realization that there is a molecular mechanism
whereby TCR/CD3 signaling initiates proliferation, comprised of
an endogenous hormone that triggers a hormone-like receptor, it
became possible for the first time to begin to separate the biochem-
ical signals generated by triggering the TCR from those triggered
by the interleukin-2 receptor (IL-2R).
Deutsch first provided evidence that an early event in mitogenic
triggering of lymphocytes might involve changes in the intra-
cellular concentration and/or transport of cations (e.g., potas-
sium, calcium) (2). Since the transmembrane electrical potential
is an important factor in the movement of charged ions across
the plasma membrane, Deutsch carefully measured it in human
peripheral blood mononuclear cells (PBMCs), and found it to be
between −35 and −52 mV. These results implied that ion gradi-
ents are maintained by energy-dependent processes in these cells,
which were not generally considered excitable cells, like neurons.
Tsien subsequently took advantage of the newly available
calcium-specific fluorescent indicator, Quin2, which made possi-
ble the first direct measurements of intracellular [Ca2+] in mouse
thymocytes and pig lymph node cells using a spectrofluorom-
eter (3). Mitogenic lectins such as phytohemagglutinin (PHA),
Concanavalin-A (Con-A), and calcium ionophores (A23187, ion-
omycin) raised intracellular calcium concentration within a few
minutes. Of note, deprivation of extracellular calcium prevented
the response. Moreover, the lectin-induced intracellular [Ca2+]
increases were sufficient to hyperpolarize the membrane poten-
tial, from−50 to−70 mV, which the authors speculated was likely
due to a K+ conductance.
Nishizuka provided insight regarding the biochemical mecha-
nism(s) whereby various cell surface receptors could transfer infor-
mational signals from the cell surface into the cellular interior with
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his path-breaking reports of two routes, protein kinase-C (PKC)
activation and Ca2+ mobilization (4, 5). The signal-dependent
breakdown of inositol phospholipids, particularly phosphatidyli-
nositol bisphosphate (PIP2), was found to be the key event for ini-
tiating these processes. After stimulation of surface receptors, PIP2
is degraded immediately to produce 1,2-diacylglycerol and inositol
1,4,5-triphosphate (IP3). He showed that this turnover of mem-
brane phospholipids is associated with an increase in intracellular
[Ca2+], and the diacylglycerol produced initiates the activation of
a calcium-dependent PKC. Thus, the extracellular receptor trigger-
ing information is transferred directly across the lipid membrane
bilayer via breakdown of membrane phospholipids and ultimately
results in intracellular protein phosphorylation.
Although these reports were suggestive that perhaps TCR/CD3
triggering could very well operate via this newly discovered trans-
membrane signal mechanism, the step from polyclonal mitogenic
activation vs. monoclonal activation remained to be defined.
Accordingly, Reinherz and collaborators used flow cytometry to
analyze Quin2 fluorescence upon anti-TCR monoclonal antibody
(MoAb) as well as anti-CD3 MoAb activation of T cell clones (6).
When coupled to Sepharose beads, anti-TCR and anti-CD3 both
caused a rapid increase in intracellular [Ca2+]. It is noteworthy
that IL-2 did not cause any change in intracellular [Ca2+], despite
promoting cellular proliferation. Also, removal of extracellular
calcium using the chelator EGTA blocked anti-TCR and anti-CD3-
induced proliferation of both cytolytic and helper/inducer T cell
clones, but did not prevent IL-2-mediated proliferation.
Others took advantage of the human T cell leukemic cell line,
JURKAT, which had been found to produce IL-2 when stimu-
lated with mitogenic lectins (7, 8). Weiss working in John Stobo’s
group showed that JURKAT clones would also produce IL-2 when
activated by soluble anti-CD3, provided phorbol myristic acetate
(PMA), which Nishizuka had shown to activate PKC, was also
present (9). Weiss and coworkers then showed that soluble anti-
CD3 MoAbs promoted a rapid increase in intracellular [Ca2+],
as did PHA and calcium ionophore, and that the combination of
PMA+ionophore promoted the production of IL-2 (10). Accord-
ingly, these studies indicated that activation of both PKC and a
rapid increase in intracellular [Ca2+] were required to promote
IL-2 production, and taken together with Reinherz’s results, they
indicated that solid phase but not soluble MoAbs reactive with
either the antigen recognition chains of clone-specific TCRs or
the pan-T cell signaling complex, CD3, activated both PKC and
an increase in intracellular [Ca2+]. By comparison, IL-2 did not
appear to operate via this pathway. Moreover, exactly what tran-
spired between these early biochemical changes in T cells, which
occurred within minutes of TCR/CD3 triggering, and the activa-
tion of IL-2 gene expression, which required at least an hour of
continuous TCR/CD3 stimulation remained to be explored.
MOLECULAR MECHANISMS OF CELL-MEDIATED CYTOLYSIS
Subsequent to the original description of cell-mediated lysis of
51Cr-labeled target cells (11), the mechanisms responsible for this
phenomenon remained obscure, especially at the molecular level.
However, Henkart’s team first showed via electron microscopy
that human mononuclear cells punctured tubular holes into the
membranes of susceptible target cells during antibody-dependent
cellular cytotoxicity (ADCC), very similar to the morphology of
complement-mediated lysis (12). Subsequently, Podack and Den-
nert found that cloned murine natural killer (NK) cells (13) and
cloned alloantigen-specific murine IL-2-dependent CTL (14) pro-
duced similar circular membrane lesions in target cells that arose
by membrane insertion of tubular complexes, which they con-
jectured were assembled from subunits during the cytolytic reac-
tion, like the terminal components of complement. The tubules
were detected on target cell membranes by immune electron
microscopy and appeared to form transmembrane channels as
seen in ultrathin sections.
To move toward a molecular explanation of these observations,
Podack was ideally situated because he had already studied the
complement components for several years with Muller-Eberhard.
Even so, a major hurdle remained to be surmounted to move from
these analytical morphological descriptions to a detailed molec-
ular analysis of the phenomena. One of our perplexing findings
noted as soon as we had successfully created the first cytotoxic T
lymphocyte lines (CTLL) (15) and clones (16) was the appearance
of the CTLL upon light and electron microscopy. The cytoplasm
of the cells after methanol fixation and procession for staining
by Wright–Giemsa revealed many granule-shaped cytoplasmic
holes. Electron microscopy revealed that these organelles con-
tained electron dense material. Podack hypothesized that these
putative granules were the elusive cytotoxic granules of CTL, so
that he took advantage of the capacity to grow up large numbers
of CTLL-2 in IL-2-containing Con-A T cell supernatant (CAT-
SUP). He generated >109 cells that he used to isolate and purify
the cytoplasmic granules. The plasma membranes were disrupted
by N2 cavitation, and post nuclear supernatants were applied to
self-generated Percoll density gradients, fractions of which were
analyzed by structural analysis using electron microscopy, and
for function by assaying for cytolytic activity in the presence and
absence of calcium using sheep and rabbit erythrocytes as tar-
gets. The fractions containing very pure granules by EM yielded
detectable cytolytic activity (17). SDS-PAGE of the fractions con-
taining cytolytic activity revealed six characteristic bands, ranging
in molecular sizes from 75 to 10 kDa under reducing conditions.
This study represented the first demonstration of strong, calcium-
dependent cytolytic activity of isolated CTL granules. Similar
results for cytolytic granules isolated from large granular lym-
phocyte (LGL) tumor cells were reported by Pierre and Maryanna
Henkart and their co-workers, so that it appeared that both CTL
and NK cells lysed target cells using similar granules (18).
To approach the purification of the active proteins found in
the cytolytic granules, Podack together with Young and Cohen
(19), prepared 5 mL of packed cells from 6 L cultures of CTLL-2
cells containing 10–15% CATSUP. Granules with cytolytic activity
purified from these packed cells via Percoll density-gradient cen-
trifugation were mixed with 1 M phosphate buffer (pH 7.4), which
precipitated the Percoll, allowing its easy removal by centrifuga-
tion. The transparent supernatant was then purified via gel filtra-
tion, fractions from which were assayed for protein and hemolytic
activity, then pooled and further purified via ion exchange high
pressure liquid chromatography (HPLC). Hemolytic fractions
from this column were pooled and analyzed by SDS-PAGE, which
yielded a single 75 kDa protein,which was provisionally designated
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protein-1 (P1). Analysis for hemolytic activity showed that lysis
was Ca2+-dependent, inhibited by Zn2+ ions and accompanied
by polymerization to form membrane-associated tubular com-
plexes that formed large transmembrane pores,which caused rapid
membrane depolarization in the presence of Ca2+. Masson and
Tschopp, simultaneously purified a similar single protein from the
cytolytic granules of another IL-2-dependent CTL line, terming
this protein “perforin” (20).
These findings led to the inevitable comparison of P1/perforin
to C9, the terminal lytic component of complement, and the con-
jecture that P1/perforin and C9 might have arisen from a common
ancestral cytolytic protein that subsequently became specialized
in cell-mediated and humoral cytolysis respectively. To pursue
this hypothesis, Podack and his collaborators generated mono-
specific antisera reactive to both denatured and native C9 and
P1/perforin (21). Cross-reactivity with P1/perforin and C9 was
found using antisera reactive with denatured proteins but not by
antisera reactive with native proteins, thereby indicating that the
two proteins shared primary sequence epitopes, but not necessarily
tertiary epitopes.
The next step, the identification and cloning of cDNA encod-
ing P1/perforin, was accomplished by Podack’s team using the
perforin-specific antisera and an expression λgt11 phage library
constructed from murine CTLs (22). The predicted amino acid
sequence contained 554 residues and as expected, displayed con-
siderable homology with certain functional domains of C9, C8α,
C8β, and C7. Also noteworthy, consistent with Reinherz’s find-
ing of both CD8+ and CD4+ cytolytic T cell clones restricted
to major histocompatibility complex (MHC) Class I and Class
II encoded molecules, perforin mRNA was detectable in both
class I and class II restricted cytolytic T cell clones, but not in
non-cytolytic T cell clones or in other non-cytolytic cells. Thus,
as predicted within a few years of the generation of monoclonal
IL-2-dependent functional cytolytic T cells (16), an initial molec-
ular mechanism whereby cytolytic T cells kill target cells became
evident for the first time.
In parallel, other investigators pursued a somewhat different
path to discern the molecular mechanisms responsible for CMC.
Chang and Eisen reported that an irreversible protease inhibitor,
N α-tosyl-l-lysyl-chloromethyl ketone (TLCK), markedly reduced
MLC-generated CTL activity monitored by 51Cr release assays
(23). Subsequently, Eisen’s group demonstrated that murine
alloreactive IL-2-dependent CTL clones had remarkably high ser-
ine esterase activity in detergent lysates (24). By comparison,
non-cytolytic cells contained little, if any esterase activity. Of inter-
est, cytolytic activity from CTL lysates, but not intact CTL activity,
was inhibited completely by the irreversible esterase inhibitors,
DFP and PMSF, suggesting that normally the serine esterase was
located internally and not expressed on the cell surface.
Independently a group led by Bleackley and another group
led by Weissman used CTL clones to isolate and identify cDNA
encoding novel T cell-specific serine proteases (25–27). Then,
using the granules purified from two CTL clones, Masson and
Tschopp isolated eight distinct serine proteases, designating them
Granzymes A–H (28). Accordingly, the prophecy that normal CTL
clones and their granules would allow the identification of the
molecular mechanisms of lymphocyte-mediated cytolysis proved
prescient (16). Even so, the identification of perforin/P1/cytolysin
and Granzymes did not immediately answer the question as to
how CTL and NK cells actually utilized these molecules to effect
specific lysis of their target cells.
Apoptosis is a term from the Greek used to describe the “drop-
ping off” or “falling off” of petals from flowers or leaves from
trees. Kerr et al. coined the term to describe “a general mechanism
of controlled cell deletion, complimentary to mitosis in the regula-
tion of cell populations” (29). They described cellular apoptosis as
structural changes initiated or inhibited by a variety of environ-
mental stimuli, involving nuclear and cytoplasmic condensation
and breaking up of the cell into a number of membrane-bound,
ultrastructurally well-preserved fragments.
Russell and co-workers first showed that CMC led to release
of both 51Cr from the cytoplasm and 125IUdR from the nucleus,
whereas lysis of the same cells by antibody+ complement or hypo-
tonic shock led solely to the release of cytoplasmic 51Cr (30).
Moreover, the intracellular disintegration of the nucleus occurred
within minutes of CTL–target cell interaction, leading to two pos-
sible explanations, “(1) The CTL injects degradative substances into
the target cell, or (2) the target cell autolyzes itself in response to a
signal from the CTL delivered at the plasma membrane” (31).
Duke and co-workers summarized the data accumulated on
the mechanisms responsible for CMC, which could be separated
into three distinguishable stages (32). The first step involved tar-
get cell recognition and establishment of a stable effector:target
cell contact or conjugate. This step required Mg2+ or Ca2+. The
second step was found to be strictly Ca2+-dependent and con-
stituted the “lethal hit” stage, during which the target cell was
irreversibly committed to lysis. The third step involved effector
cell independent target cell disintegration, wherein cytoplasmic
macromolecules were released. Notably, all of these steps were
found to be independent of protein and RNA synthesis, which were
known attributes of apoptosis in other cell systems. Nevertheless,
operating with the hypothesis that CMC might entail an apop-
totic mechanism, these investigators showed for the first time that
within minutes of exposure of target cells to antigen-specific CTL,
their nuclear DNA began to fragment and preceded cytoplasmic
51Cr release by at least an hour. By comparison, killing mediated
by heating, freeze/thawing, or lysing with antibody and comple-
ment did not yield DNA fragmentation. Furthermore, agarose gel
electrophoresis of target cell DNA showed discrete multiples of
~200 bp subunits, a characteristic of apoptosis, “suggesting that
DNA fragmentation was the result of activation of a specific endonu-
clease” (32). Despite these findings, these investigators pointed
out that CMC-mediated DNA fragmentation differed from other
examples of apoptosis, in that it did not require transcription
or translation, presumably necessary to produce an endogenous
nuclease.
One hypothesis that could serve to synthesize and recon-
cile all of these experimental data, including the inhibition of
CMC by specific protease inhibitors, was that the CTL granules
contained a pore-forming protein, perforin/cytolysin, which pro-
vided the conduit through which granule proteases, Granzymes,
gained entrance to the target cell, liberating DNA, thereby lead-
ing to its rapid digestion. Accordingly, Henkart’s group provided
the first data in support of this hypothesis: “Although fully lytic
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concentrations of purified granule perforin/cytolysin alone failed to
induce target cell DNA release, a combination of purified granzyme A
and perforin/cytolysin induces substantial DNA release” (33). Subse-
quently, Greenberg’s team reported similar findings from a serine
esterase and cytolysin/Perforin purified from a rat NK tumor cell
line (34). Consequently, two decades after the first description of
51Cr release (11), and a decade after the first description of cloned
antigen-specific CTLs (16), the molecular mechanisms responsible
for CMC became evident to everyone.
TOLERANCE OF SELF VIA NEGATIVE SELECTION
In developing his theory of Clonal selection, Burnet necessar-
ily had to account for the phenomenon of tolerance to self-
bodily components that had been shown to develop during
embryogenesis (35, 36).
Burnet stated:
“In the Burnet–Fenner theory (of antibody formation) (37),
any potentialities of antibody production against body com-
ponents were eliminated by the development of tolerance.
In the present theory they are more readily disposed of by
assuming that – at this particular stage of embryonic life –
contact with the corresponding antigenic pattern results in
the death of the cell. If the potential antigen persists long
enough in high enough concentration, all clones which can
produce this natural (auto) antibody will be eliminated”(38).
Of course, Burnet did not elaborate on the mechanism whereby
self-reactive clones were eliminated, and this aspect of his the-
ory had to be left to the future. Also, Burnet was writing before
thymic-dependent maturation of T lymphocytes had been dis-
covered (39–41), so that his view of immunity was restricted to
humoral immunity. Even so, by definition, tolerance had to be
antigen-specific, because it resulted in the capacity of the immune
system to ignore self-antigens specifically. Accordingly, Burnet had
to propose that antigen-specific self-reactive clones must be some-
how deleted or otherwise inactivated, i.e., rendered anergic, during
embryogenesis.
Further progress in this area had to await the identification of
surface immunoglobulin as the molecular basis of the B cell anti-
gen receptor (BCR) (42, 43), and the elucidation of the molecular
nature of the TCR, which required another decade (44–46). More-
over, the generation of antibody-forming cells (AFCs) to most
antigens was inextricably linked to “help” derived from T cells, so
that the underlying molecular basis for the development of B cell
tolerance necessarily depended on understanding T cell tolerance.
A breakthrough in the search for the mechanism(s) under-
lying T cell tolerance was reported by Kappler and colleagues,
who generated a MoAb that reacted with all T cells that expressed
TCRs encoded by β-chain variable gene segments specified by the
variable gene region Vβ17a (47). Moreover, T cells bearing Vβ17a-
encoded receptors that reacted with cells that expressed the MHC
Class II protein, IE. Using this MoAb, it was found that T cells
expressing Vβ17a were selectively eliminated from the mature thy-
mocyte and peripheral T cell populations of mice expressing MHC
class II IE, but were present in the expected numbers in immature
thymocyte populations (48). These observations were consistent
with the notion, as proposed originally by Burnet, that tolerance
to self-antigens (in this case self-MHC-encoded molecules) is due
to clonal elimination. In addition, their findings indicated that the
elimination of self-reactive thymocytes occurred in the thymus
as immature thymocytes were selected to enter the mature thy-
mocyte pool. All of these experiments were possible because the
Vβ17a TCRs amounted to as much as 10–20% of all the TCRs.
Despite these provocative findings, it still remained unclear
whether this phenomenon was restricted to recognition of MHC-
encoded self-molecules, or indeed whether other so-called “nomi-
nal” self-antigens associated with MHC-encoded molecules would
also react with particular TCR Vβ gene segments. Subsequently, in
the course of screening peripheral T cells and mature cortisone-
resistant thymocytes from various inbred mouse strains using a
MoAb that recognized all TCRs encoded by Vβ6 gene segments,
MacDonald and coworkers made the serendipitous observation
that Vβ6+ T cells correlated negatively with the expression of one
allele of the “minor lymphocyte-stimulating” (Mls) gene locus in
all inbred mouse strains tested (49). At the time of these studies, the
structure and function of the Mls gene product(s) were unknown.
However, Mls was remarkable, in that it was the only antigen other
than the MHC-encoded molecules that could specifically stimulate
proliferation of a high proportion of lymphocytes from unimmu-
nized mice. These findings were interpreted as providing “unequiv-
ocal evidence that expression of a particular V β segment confers
preferential T cell reactivity in vitro to Mls-encoded determinants
and that TCRs using V β6 are selected against in the thymus of mice
that express Mls-encoded gene products.” Thus, they felt that, consis-
tent with Burnet’s proposal, tolerance is mediated by the deletion
of self-reactive clones rather than by alternative mechanisms such
as anergy or peripheral suppression. Very similar findings were
reported simultaneously by Kappler and coworkers (50).
Although these reports were certainly consistent with Burnet’s
conjecture that tolerance results from the deletion of immature
autoreactive cells, because specific peptide antigen-reactive T cells
had not been shown to be deleted, the question remained open.
Obviously, the problem was the detection of very scarce antigen-
reactive cells, made impossible by the tremendous diversity of
antigen recognition. The development of transgenic mice first by
Ruddle’s group (51), and then by Brinster and coworkers (52, 53)
provided the necessary tools to analyze the mechanisms responsi-
ble for self-tolerance to specific peptide epitopes in vivo. Thus, von
Boehmer and team took advantage of monoclonal T cells cytolytic
for peptides specified by the male minor histocompatibility anti-
gen (HY) that they had generated using female T cells stimulated
by male T cells in vitro, and cloned by limiting dilution using IL-
2-containing media (54) (see Toward a Molecular Understanding
of Adaptive Immunity: A Chronology, Part II). They chose one of
their clones for study because it’s TCRβ-chain could be recognized
by a MoAb specific for all three members of the Vβ8 gene family
(55). They then injected fertilized eggs with genomic DNA harbor-
ing the productively rearranged TCR α and β genes isolated from
the HY-specific cytolytic T cell clone (56). The transgenic founder
mouse contained four copies of the TCR-α and two copies of the
TCR-β transgenes integrated on the same chromosome. Notewor-
thy, the presence of the transgenes inhibited the expression of the
endogenous α and β TCR genes, with the result that the major-
ity of T cells expressed the transgenes (55). Thus, they essentially
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created in vivo clonal T cells, thereby circumventing the complex
TCR repertoire, so that the fate of transgenic T cells expressing only
one TCR complex reactive with a single peptide could be studied.
T cells with the phenotype of the cytolytic HY-specific clone
were found to be frequent in female, but not in male transgenic
offspring, despite the fact that peripheral T cells in animals of both
sexes expressed both transgenes. Peripheral T cells in male, but not
female mice, had an abnormal CD4/CD8 phenotype, in that over
90% of T cells in the lymph nodes of male transgenic mice lacked
the expression of both CD4 and CD8, or expressed very low lev-
els of CD8. Moreover, there were very few CD4+CD8− T cells.
This unusual phenotype of peripheral male T cells was a con-
sequence of the deletion of autospecific HY-reactive thymocytes
that expressed high densities of CD8 molecules, predominantly
cortical CD4+CD8+ immature thymocytes. Therefore, these data
supported the interpretation that double-positive cortical thymo-
cytes are precursors of single-positive mature thymocytes, and that
the accessory molecules CD4 and CD8 are important for the dele-
tional process. Moreover, these data first established that negative
selection of self peptide-specific T cells occurs as a consequence of
TCR recognition of self-peptide.
Accordingly, all of these data confirmed Burnet’s prediction
that tolerance to self-autoantigens, at least in the T cell com-
partment, occurs via the deletion of cells capable of recognizing
self-peptides. Moreover, the data from the TCR transgenic mouse
experiments were especially convincing that the TCR and the
accessory molecules, CD4 and CD8, which confer antigenic speci-
ficity and sensitivity, were responsible for initiating the deletional
process. However, these experiments did not yield any insight into
the molecular mechanism(s) operative. In other words, these data
revealed “what happens,” but they did not provide any clues as to
“how it happens.”
NEGATIVE SELECTION: ROLES OF THE TCR VS. IL-2 IN
TRIGGERING APOPTOSIS
Almost simultaneously, as experiments were reported by inves-
tigators focused on genetic approaches in tolerance induction,
others were exploring biochemical and immunological approaches
to understand T cell maturation and selection in the thymus.
Experiments reported by Raulet using flow cytometric analysis
revealed that a small thymocyte subpopulation lacks expression
of both CD4 and CD8 TCR accessory molecules, and contains
the most immature cells (~3% of adult thymocytes). As MoAbs
capable of recognizing what is now known as the IL-2Rα chain
became available (57–59), ~1/3 of this “double-negative” thymo-
cyte subpopulation, or only 1% of all thymocytes, were found to
express this cytokine receptor chain (60). In addition, double-
negative fetal thymocytes were also positive for IL-2Rα chain
expression. Even so, it is noteworthy that when exposed to purified
recombinant human IL-2 (rhIL-2), the immature double-negative
thymocytes proliferated poorly, thus questioning whether most
of these immature IL-2Rα+ thymocytes expressed a functional
IL-2R, and also whether IL-2 itself was involved in thymocyte pro-
liferation and differentiation. This was especially cogent, given that
Con-A without IL-2 supplementation was ineffective in stimulat-
ing thymocyte proliferation, indicating that immature thymocytes
could not produce IL-2. Moreover, IL-2Rs were undetectable on
the double-positive thymocytes subset, which makes up the major-
ity of immature thymocytes, ~90% and the stage where negative
selection appeared to be taking place.
From the earliest experiments with IL-2-dependent CTLL, it
was observed that IL-2 deprivation for even a few hours would
lead to irreversible cell death, although the mechanism(s) respon-
sible were totally obscure (61). Accordingly, of interest soon after
Raulet’s thymocyte experiments, Duke and Cohen reported that
IL-2 withdrawal from IL-2-dependent proliferating CTLL and
helper T cells results in extensive chromatin cleavage that precedes
plasma membrane breakdown by several hours (62). The DNA
fragments observed were not randomly generated but consisted of
regular sized oligonucleosomes. Noteworthy was the finding that
DNA fragmentation, like cell death, did not occur in the presence
of protein synthesis inhibitors, suggesting that IL-2 deprivation
leads to the activation of the expression of an endogenous endonu-
clease specific for linker DNA. All of these data indicated that
IL-2-deprivation cytolysis occurs via a suicide program with all of
the classic signs of apoptosis.
A subsequent analysis of murine thymocyte expression of CD3,
CD4, and CD8, and reactivity to stimulation via anti-CD3 by Alli-
son and coworkers revealed that 80% of adult thymocytes express
both CD4 and CD8 (i.e., double-positive), 3% express neither
(double-negative), 12% only express CD4 (CD4 single-positive,
and 3% expressed CD8 alone) (CD8 single-positive) (63). Note-
worthy, there was a distinct difference in CD3 density among the
subsets,with the single-positive cells expressing the highest density,
while the double-positive cells expressed only a low density of CD3.
In this report, about half of the double-positive cells expressed
detectable CD3. To assess the functionality of the CD3 signaling
molecules expressed by double-positive thymocytes, by compari-
son with single-positive peripheral T cells isolated from the spleen,
single cell intracellular calcium concentrations were measured
using flow cytometry. It was obvious that the anti-CD3-triggered
increased intracellular Ca2+ concentrations of double-positive
thymocytes were only about half of the mature peripheral splenic T
cells. However, PKC, like calcium second messengers a product of
CD3-induced phosphatidylinositol 4,5-bisphosphate hydrolysis,
was activated by anti-CD3 stimulation of murine double-positive
thymocytes.
As the components of the early steps of T cell activation
appeared to be functional in double-positive thymocytes, the
expression of the IL-2Rα-chain and the production of IL-2 were
assessed next (63). In contrast to mature peripheral single-positive
splenic T cells, the double-positive thymocytes failed to produce
IL-2 or to express the IL-2Rα-chain, and to proliferate, even if irra-
diated macrophages to serve as a source of IL-1 were present. Also,
noteworthy was the lack of a proliferative response of the double-
positive thymocytes, even if IL-2 was added exogenously, thereby
indicating the lack of functional IL-2R expression in response to
anti-CD3 stimulation. Accordingly, the CD4CD8 double-positive
thymocytes undergo negative selection when triggered via their
TCR/CD3 complex by self-peptide/MHC complexes in vivo, but
the TCR/CD3 complex expressed by these cells appears imma-
ture, incapable of promoting transcription and translation of
genes such as IL-2 and the IL-2Rα-chain, which are required
for a proliferative response by mature peripheral single-positive
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T cells in vitro. Thus, a plausible mechanism for the apoptosis
underlying negative selection is the lack of IL-2 production and IL-
2R expression by TCR/CD3-triggered immature double-positive
thymocytes, in that without the IL-2-derived pro-survival and pro-
liferative/differentiative signals, premature TCR/CD3 triggering
may well activate apoptosis as a default pathway.
These data were confirmed and underscored by Reinherz’s
group who studied human thymocytes compared with peripheral
mature T cells (64). Using the unique observation that CD3− thy-
mocytes could be triggered to proliferate via activation by MoAbs
reactive with anti-CD2, they found that anti-CD3 would actually
inhibit this proliferative response. In examining this phenomenon
further, they found that CD3+ thymocytes, like their murine coun-
terparts, could not be triggered to proliferate, and that anti-CD3
stimulation did not promote IL-2 production, but did lead to IL-
2R expression. Moreover, anti-CD3 activation actually suppressed
IL-2 gene expression stimulated by anti-CD2. Thus, by compari-
son with mature peripheral T cells, triggering CD3+ thymocytes
with anti-CD3 leads to a rapid suppression of IL-2 gene expres-
sion, thereby preventing the cells from receiving the pro-survival
and proliferative effects of IL-2, thus creating a situation imitating
cytokine withdrawal apoptosis. Therefore, TCR/CD3 activation
of immature thymocytes results in an active suppression of IL-2
gene expression, not simply a passive lack of IL-2 gene activation.
This begs the question as to the mechanism responsible, which
remained obscure.
This conjecture was supported by Jenkinson and colleagues,
who studied the effects of anti-CD3 on thymocytes in fetal organ
culture, which provides an in vitro system that can support TCR
gene rearrangement and expression, and avoids the problem of low
viability encountered in cultures of isolated thymocytes (65). They
found that anti-CD3 added for the last 18 h of culture resulted
in a substantial reduction in cell yield (~43%), and the chro-
matin condensation and cell shrinkage characteristic of apoptotic
cells detectable by electron microscopy, as well as the degradation
of DNA to oligonucleosomes characteristic of apoptosis. Simi-
lar results were obtained using a MoAb reactive with TCR Vβ8, as
well as a super-antigen, staphylococcal enterotoxin-B, reactive with
TCR Vβ8+ cells. Accordingly, these data are all consistent with the
conclusion that triggering of immature CD4CD8 double-positive
thymocytes either via MoAbs reactive with CD3, or MoAbs and
superantigens reactive with specific TCR Vβ8+ cells, results in
apoptosis rather than activation (66).
POSITIVE SELECTION-MHC AND ENDOGENOUS PEPTIDE
A picture is worth a thousand words, they say, and thus the deter-
mination of the structure of human Class I histocompatibility
leukocyte antigen (HLA) from crystallized protein by Bjorkman, a
student working with Wiley and Strominger, rocked the immuno-
logical community (67). Since the pioneering experiments of
Schlossman (68) and path-breaking findings of Unanue and
Askonas more than 20 years earlier (69), it had become established
that T cells recognize short peptides (~6–20 residues), digested
and presented by antigen presenting cells, somehow complexed to
molecules encoded by genes of the MHC.
However, without any knowledge of the structure of these mol-
ecules, it was difficult to imagine how the myriad of foreign
peptides (estimates of ~107) could interact with each MHC
encoded molecule, and furthermore how a single TCR recognized
or interacted with the peptide–MHC complex. Accordingly, the
shock from visualizing the first HLA molecular structure was find-
ing the peptide-binding groove situated between two alpha helices
(67). Also, finding the groove to be already occupied with what
ultimately turned out to be an endogenous peptide that persisted
throughout the entire purification and crystallization procedure
suggested that a peptide, either self or non-self, is always bound to
the histocompatibility molecules (70).
Thus, by 1987 it was established that a single TCR recognizes a
single peptide–MHC complex, and as a consequence of the work
of Bjorkman and colleagues, it was finally understood exactly how
peptides complexed with the MHC-encoded molecules to form
a single peptide/MHC antigen recognition molecule. However,
even before the discovery of MHC restriction of T cell antigen
recognition, Jerne had proposed that the germ cells of an animal
carry a set of genes encoding the combining sites of lymphocyte
receptors which he hypothesized were directed against a complete
set of MHC-encoded antigens of the species to which the ani-
mal belongs (71). Subsequently, it was reported that precursor T
cells differentiate recognition structures for self-MHC molecules
expressed on the thymic epithelial cells (72, 73). However, exactly
how this phenomenon occurred remained obscure.
The two subsets of T cells distinguished by their expression of
either CD4 or CD8 molecules were first delineated by Reinherz’s
group, who studied human PBMCs (74, 75), and then human IL-
2-dependent cytolytic CD8+ and CD4+ T cell clones (76). Several
years after the work with human T cells, a MoAb that reacts with the
murine equivalent of CD4 was developed by Fitch’s group, allow-
ing Swain to confirm the correlation between CD4 expression and
MHC class II restriction of antigen recognition in the murine sys-
tem (77). Analysis of all of Reinherz’s human T cell clones revealed
CD8+ T cells to be MHC Class I restricted, whereas all CD4+ T cell
clones were MHC Class II restricted in their capacity to recognize
antigens (76). Noteworthy from these data was the observation
that both MHC Class I restricted and MHC Class II restricted T
cell clones were capable of cytolysis as determined by the standard
4-h 51Cr release assay. However, in addition, CD4+ MHC Class II
restricted T cell clones could also provide T cell“help”for antibody
production, and thus could be “helper” T cells (Th). Accordingly,
although cytolytic T cells (Tc) were traditionally considered CD8+
while Th cells considered CD4+, this discrete separation was not
supported by the data derived from T cell clones (76). Instead, CD8
expression correlated with MHC Class I antigen recognition, while
CD4 expression correlated with MHC Class II antigen recognition.
Thus, it was proposed that mature peripheral thymic-derived
cells are somehow “positively selected” from immature thymo-
cytes by MHC-encoded molecules expressed on thymic stromal
cells, and upon emerging from the thymus, the TCRs of these
cells would bind foreign peptide antigens that are already bound
to self-MHC encoded molecules. Accordingly, should this be the
case, von Boehmer hypothesized that in the absence of foreign
peptides during thymopoiesis, the interaction of the TCR with
Class II and Class I thymic self-MHC molecules should direct
or select for the differentiation of immature T cells into single-
positive CD4+ and CD8+ mature T cells respectively (78). Thus,
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von Boehmer’s team focused on female TCR transgenic mice that
recognized the male-specific HY antigen, because this antigen was
absent during thymopoiesis in these animals. Theoretically, female
mice should “positively select” CD8+ T cells capable of recogniz-
ing HY peptide/self-MHC, but not self-MHC without HY peptide,
or HY peptide and a third party Class I MHC. Their results were
consistent with this hypothesis, i.e., that the interaction of Class I
MHC-encoded molecules in the thymus with theαβheterodimeric
TCR determines the CD4/CD8 phenotype of mature T cells in the
absence of reactive foreign peptide (78).
To investigate further the specificity of the “positive selection”
exerted by MHC-encoded molecules, the von Boehmer team per-
formed thymus repopulation experiments (79): lethally irradiated
females of recombinant strains that differed at D and K through
to the S sub-regions of the MHC, were transplanted with bone
marrow cells from H-2b TCR αβ HY-specific transgenic female
mice. Five weeks after transplantation, the repopulating capacity
of the donor stem cells, as estimated from the cellularity of the thy-
muses of the recipients, correlated with the degree of compatibility
within the MHC: the highest numbers of thymocytes (~5× 107)
were recovered from syngeneic and semi-allogeneic recipients, the
lowest (~8× 106) from allogeneic recipients differing across the
whole MHC. These investigators went on to hypothesize “that
the specific low affinity interaction of the TCR with thymic stromal
MHC-encoded molecules is sufficient to select immature T cells but
insufficient to activate mature T cells. The specific low affinity inter-
action in the thymus may be complemented by accessory molecules
(CD4/CD8 co-receptors) present on either immature thymocytes
or selecting thymic stromal cells, or both. Such a complementation
could then lead to the positive selection of T cells with low affinity for
self-MHC.”
Entirely consistent with these findings and hypothesis, von
Boehmer’s group followed up their in vivo findings with in vitro
experiments using double-positive thymocytes from female H-2b
TCR αβ HY-specific transgenic mice. When exposed to thymic or
splenic adherent cells from male H-2b mice during 24–48 h of sus-
pension culture, deletion of double-positive female thymocytes
occurred only in the presence of cells bearing HY antigen with
the appropriate (H-2b) MHC-encoded molecules. These findings
indicated that the deletion of double-positive thymocytes is not
a unique property of the thymic microenvironment, but is the
property of a certain developmental stage of T cells, which makes
it sensitive to deletion. Thus, female double-positive thymocytes
will be deleted when exposed to the HY-antigen presented by the
proper MHC-encoded molecules in vitro, just as the male double-
positive thymocytes are deleted in vivo, when exposed to their own
self-antigen. Also noteworthy, is the fact that female single-positive
CD8+ mature peripheral T cells do not undergo apoptosis when
confronted with HY+ APCs. Rather, they undergo activation and
clonal expansion, underscoring the interpretation that immature
double-positive thymocytes are negatively selected because of their
immaturity.
It is also noteworthy that the hypothesis to explain these find-
ings of positive and negative selection, i.e., that there must be a
difference in the affinity of self-antigen stimulation of the TCR-co-
accessory molecular complex to account for such disparate fates
of life vs. death, remained untested at the time in the early 90s.
A further, unexplored aspect of positive selection is the ques-
tion of whether, like negative selection, a self-peptide occupies
the groove of the MHC-encoded molecules in the thymus, such
that all positively selected T cells that exit the thymus and pop-
ulate the periphery have the capacity of reacting to self, should
the self-peptide concentration become high enough to surpass a
putative threshold, leading to T cell activation, proliferative clonal
expansion and differentiation to become effector cells capable of
autoimmune reactivity. Alternatively, perhaps there is a peripheral
tolerance mechanism that functions to prevent auto-recognition
and activation. These considerations would necessarily be the
subjects of future investigations.
MOLECULAR MECHANISMS OF T CELL “HELP”
One of the purposes of the creation of the interleukin nomen-
clature, whereby the molecules were simply numbered, was the
anticipation of additional new and novel interleukins yet to be
discovered. In this regard, murine Th clones had already been
generated using CATSUP by Schreier and co-workers (80, 81).
Thus, operating with the hypothesis that there must be a Th cell-
specific growth factor or interleukin similar but different from the
CTL-specific IL-2, Hapel working in Ihle’s group, reported that
a new and novel cytokine promoted the proliferation and differ-
entiation of immature hematopoietic precursor cells of athymic
(nu/nu) mice to become Lyt-1+Lyt-2− Th cells (82). However,
these investigators appeared to be unaware that the Lyt-1 alloanti-
gen, which had been thought to mark Th cells, had been found
on all T cells, so that it did not specify the Th subset as did
the CD4 molecule expressed by human T cells (83, 84). In any
event, since IL-2 appeared to preferentially lead to the growth of
CTL at the time, it seemed reasonable that there might also by
a Th-specific growth and differentiation factor in CATSUP. Ihle’s
group had reported that conditioned media from mitogen- or
alloantigen-stimulated lymphocytes promoted the expression of
20α-hydroxysteroid dehydrogenase, which had been reported to be
associated with mature but not immature T cells (85, 86). Because
this activity appeared to target immature hematopoietic cells,
and because the initial biochemical characteristics of the activity
appeared to be different from those reported for both IL-1 and IL-
2, Ihle’s group proposed that the activity be termed IL-3. Of course,
all of this occurred before any cytokine activity had been purified
to homogeneity and attributed to a single molecule (see “Toward a
Molecular Understanding of Adaptive Immunity: A Chronology,
Part I and II”), so this nomenclature proposal was problematic.
Unbeknownst to Hapel and Ihle, Schrader had also reported
that CATSUP promoted the outgrowth of immunoglobulin-
negative, Thy-1-negative, and Lyt-1/Lyt-2-negative non-adherant
cells from murine splenocytes, which he termed “persisting cells”
(P-cells) (87). By comparison with the lack of these T cell markers,
MHC-encoded Class I and II molecules as well as Fc receptors were
readily detected on these cells. In other experiments, metachro-
matic granules were found in these cells, and they were found to
contain histamine, suggesting that the P-cells were from the mast
cell lineage (88). Schrader went on to show that the activity that
he found in CATSUP was similar to the colony stimulating activ-
ity (CSA) described by Metcalf and colleagues that promoted the
growth of mixed hematopoietic colonies of erythroid and myeloid
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cells, but was distinct from T cell growth factor (TCGF) and
T cell-derived granulocyte-macrophage colony-stimulating factor
(GM-CSF) (89).
Soon thereafter, Hapel and coworkers reported the cloning
of a cDNA encoding murine IL-3, which they identified by the
growth promoting effects of oocyte-translated mRNA on an IL-
3-dependent cell line 32D clone-23 created by Ihle’s group (90).
The nucleotide sequence predicted an amino acid sequence with
a molecular size of 15,102 Da, so that it was similar but different
from IL-2 (91, 92). Hapel’s group then collaborated with Met-
calf ’s group to show that the molecularly cloned IL-3 induced
2-α-hydroxysteroid dehydrogenase activity in splenic lymphocytes
from athymic (nu/nu) mice, in addition to proliferative activity
for 32D clone-23 and FDC-P1 cell lines, and CSA for granulocyte-
macrophage, eosinophil, megakaryocyte, NK-like, erythroid, and
multipotential colony-forming cells from murine fetal liver and
adult bone marrow (93). Thus, IL-3 was shown to promote mul-
tipotential hematopoietic stem cell proliferation, and not to be a
Th-specific growth factor.
As detailed in Part I of “Toward a Molecular Understanding of
Adaptive Immunity: A Chronology” (94), at least three cell types
were found to be required for the generation of AFCs in vitro; B
cells, T cells, and macrophages. Mitchison had shown that there
appeared to be a “linked or cognate recognition” between B cells
and helper T cells important for the mechanism of T cell help
leading to the generation of AFCs (95). Also, the contribution of
both macrophages and T cells could largely be replaced by super-
natants from these cultured cells (96, 97), so that there seemed
to be both cell-associated and soluble components to the “help”
that B cells received from T cells and macrophages. Subsequently,
during the 70s many purported to show either macrophage- or T
cell-derived soluble helper activities that promoted the generation
of AFCs, either by promoting B cell proliferation or Ig secretion
or both. However, because of the complexities of target cell pop-
ulations used in the bioassays, as well as the difficulties of protein
analysis and purification, and the intricacies of monitoring both
proliferation and Ig secretion, the field did not progress for more
than a decade.
With the advent of the generation of both cytolytic and helper T
cell clones (16, 81), the stage was set for new approaches of reduc-
tionist science to approach the question of the molecular regula-
tion of AFC generation and the contributions of both macrophages
and T cells. In particular, Schreier and coworkers generated multi-
ple Th clones specific for sheep red blood cells (SRC) or horse red
blood cells (HRC) as antigens that were amenable to the analy-
sis of their effects on AFCs using the Jerne plaque assay (98) and
the Mishell–Dutton system (99). Early on, they established that
antigen-specific Th cell clones, propagated in culture in serum-
free medium for up to 15 months, would enable nu/nu mice to
respond to T-dependent antigens in vivo by producing specific
antibodies and the formation of as much as five times the number
of AFCs as expected in a primary response of normal mice (81).
Schreier then went on to examine the nature of T cell help.
In a detailed analysis of T cell help using Th clones, and as tar-
gets either LPS-activated B cell blasts or isolated small resting
B cells, they found that Th clones released an antigen/APC-
activated MHC Class II restricted “soluble helper factor” that
promoted LPS-induced B cell blast proliferation and Ig secretion
(100, 101). This soluble “T cell helper factor” was effective regard-
less of the MHC or antigen specificity of the B cell blasts. By
comparison, small resting B cells required the physical presence
of Th clones, as well as their antigen/MHC-restricted antigen-
non-specific secreted soluble Th factor to undergo proliferative
expansion and Ig secretion. It appeared that small resting B cells
needed two signals, one derived from the Th-B cell contact from Th
antigen “linked recognition” to become responsive to the soluble
Th factor, which then promoted proliferation.
Several aspects of these results warrant analysis. First, the gener-
ation of B cell blasts for use as target cells introduced an unknown,
in that at the time the nature of the LPS-induced blastogenesis
and proliferation remained obscure. It was not at all clear why LPS
was a B cell mitogen in the mouse but not in the human (102),
and whether LPS mimicked antigen-activation or not. Second,
these experiments were performed before the molecular nature
of the TCR was realized, and before the nature of peptide anti-
gen binding to MHC-encoded molecules on APCs was known.
Thus these investigators conjectured that the “linked or cognate”
antigen recognition occurred via antigen bound to surface Ig on
the B cell (BCR) and antigen bound to the TCR on the surface
of the T cell, as proposed originally (95). However in addition,
now they suggested that, a second signal was supplied to the B cell
by the T cell, via the elusive second TCR interacting with B cell
Class II MHC-encoded molecules. Despite these complexities and
unknowns, the data generated using Th clones and B cell blasts vs.
small resting B cells were irrefutable and had to be explained.
The cellular source, as well as the molecular nature of Schreier’s
antigen-non-specific B cell replication and maturation factor
(BRMF) was obscure. Thus, the investigators stated that the cellu-
lar source of the factor “may be either the antigen-specific helper T
cell or the macrophages that interact with the helper T cell.” Also,“We
imply that one factor (molecule) induces both maturation (i.e., Ig
production) and (DNA) replication, although it is equally possible
that separate factors (molecules) govern these two reactions of a B
cell.” This same interpretation was applied in a separate report that
explored the various soluble factors produced by Th clones (103).
When Th clones were stimulated by specific antigen and histo-
compatible APCs, several apparently distinct activities appeared
in culture supernatants that promoted colony formation of var-
ious hematopoietic cells, including macrophages, granulocytes,
erythroid cells, as well as TCGF and BCGF activities. However, even
though Th clones were used rather than heterogeneous T cell pop-
ulations, because heterogeneous APCs+ antigens were required
to elicit the activities, the cellular source of each of these activities
remained unknown, i.e., whether T cell or macrophage-derived,
and also whether there were many or just one cell and molecule
responsible.
Taking a page from the TCGF/IL-2 experience, the use of cloned
Th cells at least solved the problem of the identity of the T cells used
to produce the conditioned media containing the active molecules.
However, long-term normal B cell lines and clones had yet to be
developed, so that the target B cells used for the bioassays were still
heterogeneous. Therefore, the next best approach was to use B cell
blasts obtained using activation with B cell mitogens, or alterna-
tively, B lymphoma cells, which could be cloned. Pure working in
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Vitetta’s group, in collaboration with Dennert, Swain, Dutton, and
Takatsu, studied the effects of T cell supernatants obtained from a
normal alloantigen-specific T cell line, as well as Con-A-activated
T cell lymphoma and hybridoma cells, on the proliferation and
polyclonal IgM production by anti-IgM/D-activated neonatal and
adult splenocytes as well as BCL1 lymphoma cells (104). They
found that Sepharose-bound anti-Ig induced the proliferation of
adult but not neonatal B cells, and that IgM production required
T cell supernatants, which induced the production of IgM by both
normal (neonatal and adult) and neoplastic B cells. These data
seemed to indicate that BCR stimulation led to proliferation, but
that differentiation to Ig production depended upon factors in the
T cell supernatants.
In a separate report, Swain and Dutton examined T cell replac-
ing factor (TRF) activity derived from the same alloantigen-
stimulated long-term T cell line generated by Dennert (105). Using
the classic TRF assay of Schimpl and Wecker, comprised of SRBCs
cultured with T- and macrophage-depleted splenocytes (97) as a
source of target B cells, they found that supernatants from this T
cell line had TRF activity but not IL-1 or IL-2 activity. Of note,
this TRF supernatant synergized with IL-2 in the generation of
AFCs, which was especially evident when the two activities were
titrated. They speculated that this activity could be the “late-acting
TRF,” originally described by Schimpl and Wecker, which was pos-
tulated to replace the requirement for T cells by promoting the
differentiation of antigen-stimulated B cells, facilitating the pro-
duction of IgM. However, these investigators rightly discussed the
problems associated with the interpretations of their experiments,
which used heterogeneous cell populations and T cell lines instead
of cloned cells. For example, any soluble activity might amplify
residual T cells in the purified B cell population instead of work-
ing directly on the B cells themselves. In addition, at this time no
biochemical characterizations of the TRF activity were reported.
Soon thereafter, Krammer and Vitetta reported evidence for
“B cell differentiation factor(s)” (BCDFs), which appeared to pro-
mote B cells to switch isoptypes from IgM to IgG (from ~1 to
~20% of AFCs), and especially to IgG1 (from ~40 to ~90%) (106).
As targets, they used LPS splenic B cell blasts purified by nega-
tive selection with monoclonal anti-Thy1+ complement (C’), and
supernatants from two long-term IL-2-dependent alloreactive T
cell lines stimulated with Con-A. B cells cultured for 6 days with
LPS and T cell supernatant wielded IgG AFCs, whereas no IgG
AFCs were produced by LPS alone, only IgM AFCs. These T cell
supernatants promoted the appearance of IgG from fluorescent
activated cell sorter (FACS)-selected IgG-negative B cells, and fur-
thermore, a switch from IgG2a and IgG2b/IgG3 to predominantly
IgG1 (~90%) occurred. They speculated that the LPS-dependence
of Ig production of any isotype at all suggested the necessity for a
specific signal that could have been a proliferative signal or one that
induced the expression of receptors for the BCDF(s). By means of
the traditional IL-2 and TRF assays it was determined that the
supernatants from the two T cell lines were negative, so that it was
concluded that they had identified a new activity, even though they
provided no data regarding molecular characteristics.
Simultaneously, Howard working in Paul’s group, in collabo-
ration with Farrar and Takatsu, reported the identification of a T
cell-derived B cell growth factor (BCGF) distinct from IL-2 (107),
based on a system originally reported by Parker (108). By compar-
ison with the assays of others, this group used as targets negatively
selected (various antibodies reactive with T cells+C) splenic B
cells activated for 72 h with affinity-purified goat anti-mouse IgM.
For a source of T cell activities, supernatants were obtained from a
mouse thymoma (EL4) and a T cell hybridoma activated with PMA
for 48 h. PMA was removed from the supernatants by absorp-
tion with activated charcoal. As in the IL-2 bioassay, the relative
concentrations of BCGF activities were compared by the recipro-
cal of the dilution that yielded 50% of maximal activity. When
50µg/mL of anti-IgM was used with 5× 105 cells/microwell, an
easily detectable proliferative response could be quantified with
3H-TdR incorporation without the addition of a T cell super-
natant. However, at 10-fold lower anti-IgM concentrations and cell
densities, T cell supernatants were required to promote detectable
3H-TdR incorporation. To exclude the possibility that IL-2 was
responsible for the BCGF activity, the supernatants were absorbed
with cloned IL-2-dependent T cells. Moreover, molecular gel filtra-
tion of the supernatants yielded distinct peaks of IL-2 and BCGF
activities. Both partially purified IL-2 and BCGF failed to replace
the requirement for T cells (TRF activity) in the generation of AFCs
from purified B cells+ SRBCs. However, the inclusion of all three
activities (IL-2, BCGF, and TRF) did yield AFCs. Thus, these inves-
tigators concluded that there were three activities (TCGF, BCGF,
and TRF) that functioned independently to promote B cell pro-
liferation and differentiation to AFCs. Like the model of T cell
activation and proliferation (109, 110), these investigators pro-
posed “that anti-IgM delivers a non-proliferative signal to resting B
cells, possibly causing the expression of receptors for BCGF; and that
BCGF delivers a proliferative signal to these anti-Ig activated growth
factor-sensitive B cells.”
In collaboration with Mizel and Lachman, Howard and Paul
went on to show that in addition to triggering the BCRs, opti-
mal B cell proliferation required both a T cell-derived BCGF and
a late-acting signal derived from purified IL-1 (111). From their
experiments, it was shown that this combination would only result
in B cell proliferation and not Ig secretion, and furthermore that
the target B cells had to be cultured at low cell densities (5× 104
cells/well or 2.5× 105 cells/mL) for the BCGF and IL-1 effects
to become detectable. It did not appear that the IL-1 acted by
stimulating residual T cells to produce another BCGF, similar
to the effect of IL-1 on T cells to produce IL-2 (112, 113), but
the mechanism of the IL-1 B cell proliferative effect remained
unexplored.
Swain and Dutton then collaborated with Howard, as well as
Kappler, Marrack, and Watson, to try to discern whether there
were several or only one T cell-derived BCGF (114). They found
that supernatants derived from the EL4 thymoma synergized with
anti-Ig in promoting the proliferation of normal splenic B cells,
but failed to have activity when the BCL1 lymphoma cells were the
target. This activity they termed BCGF-I. By comparison, super-
natants from the Dennert alloreactive T cell line had reciprocal
activities, promoting the proliferation of BCL1 cells, but not anti-
Ig-stimulated normal splenic B cells (BCGF-II). They discussed
the conundrum of wondering whether there were different states
of B cell differentiation responsive to different growth factors, or
whether there were different subsets of B cells involved. Again, a
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molecular characterization of the activities was lacking. However,
they went on to show that homogeneous, MoAb-purified IL-2
acted on an antigen-specific (ovalbumin) T cell line to produce
BCGF-I, thereby indicating that the various cytokine activities
found in antigen-activated T cell supernatants could very well be
interdependent (115).
Sideras working in Severinson’s group on the IgG1-inducing
factor, constructed a quantitative bioassay patterned after the
TCGF bioassay using normal LPS-stimulated splenocytes as target
cells and isotype-specific AFCs as the indicators (116). This assay
yielded parallel dose-response curves identical to those described
for the TCGF assay, and the relative concentrations obtained from
different IL-2-dependent cloned alloreactive T cells or hybrido-
mas stimulated with Con-A could be ascertained by the 50% AFC
responses. Using this assay, they found that the IgG1-inducing
activity, and the IgG3/IgG2b reducing activities, co-migrated both
quantitatively and qualitatively, thereby suggesting that they were
attributable to the same lymphokine activity. Furthermore, prepa-
rations of BCGF-I, purified via MoAb affinity (117) scored positive
in their IgG1-inducing bioassay, as well as the IgG1-inducing assay
of Vitetta. Accordingly, these data suggested that a single mole-
cule might be responsible for both B cell proliferative (BCGF) and
differentiative (BCDF) activities. Moreover, the biochemical prop-
erties of this activity differed from those reported for IL-1, IL-2,
IL-3, CSA, IFNγ, BCGF-II, and TRF (118).
To proceed beyond these experimental approaches, Severinson
collaborated with Honjo’s group to identify a cDNA encoding a
protein with IgG1-inducing activity (119). The cDNA predicted a
protein of 140 amino acid residues and a deduced M r= 15,836,
with a signal peptide of 19 residues. Thus, the predicted mature
polypeptide had a M r= 14,137 and a sequence distinct from
known cytokines, including IL-1, IL-2, IL-3, GM-CSF, and IFNαβγ.
Biological assays indicated that IgG1-inducing activity, IgG2/3-
reducing activity, B cell Ia-inducing activity, and BCGF-I activ-
ity were all attributable to the same protein. Accordingly, these
investigators proposed that this activity be termed IL-4. An iden-
tical cDNA was isolated by Lee and coworkers in Ken-Ichi Arai’s
group, who also showed that this new lymphokine had TCGF
and mast cell growth factor activities, as well as IgE inducing
activity (120).
Others working contemporaneously focused on TRF activity
and BCGF-II activity, trying to understand exactly how many
lymphokine molecules were involved in promoting B cell pro-
liferation and differentiation. Like the evolution of IL-3, which
eventually was found to have growth factor activity for multi-
potential hematopoietic cells, Sanderson and coworkers found
that an eosinophil differentiating factor (EDF) also promoted the
growth and differentiation of BCL1 lymphoma cells, thereby sug-
gesting that a single might target both myeloid and lymphoid
cells (121). Their evidence derived from a significant correlation
between the EDF and BCGF-II assays when supernatants from
39 separate T cell clones were tested, as well as coincidence in
gel filtration and HPLC elution profiles. Subsequently, Takatsu
and Severinson collaborated with Honjo’s group, and identified a
cDNA clone that coded for 133 amino acid residues containing a
21 residue leader sequence and a mature protein of M r= 12,300
(122). The entire amino acid sequence was unique, but contained
short sequences homologous to those of IL-3, GM-CSF, and IFNγ,
thereby suggesting that it belonged to a cytokine family. Because
this new and novel protein demonstrated both TRF and BCGF-II
activities, it was proposed to be termed IL-5.
Independently of all of these efforts, but focused on the same
goals, Kishimoto’s group developed bioassays for human B cell Ig
production from B cell lymphomas as well as B blast cells iso-
lated from Staphylococcal-A-activated human tonsil cells (123).
As a source of T cell-derived factors, they established a human T
leukemia cell line that spontaneously released an activity that pro-
moted Ig production. Hirano identified proteins of 19 and 21 kDa
(M r), which he purified to homogeneity using several preparative
steps, assaying relative concentrations using the reciprocal of the
dilution that yielded 50% maximal Ig production as in the TCGF
bioassay (123). cDNA probes were constructed based on amino
acid sequences of the purified proteins, and used to identify clones
from a cDNA library from the leukemic T cells that encoded a
novel protein of 212 amino acid residues with 28 hydrophobic
residues in the N-terminus (124). Thus, the mature protein con-
sisted of 184 amino acids and a calculated M r= 20, 782. Of the
known cytokine sequences, only human G-CSF showed signifi-
cant homology. Tests of biological activity of the purified protein
indicated that this new cytokine promoted Ig production by both
normal and malignant human B cells, but did not promote B cell
proliferation (125). Subsequently, this molecule became known
as IL-6.
Thus, more than 15 years after the first descriptions of
macrophage and T cell-derived activities found to “help” AFC
formation and Ig production, three new interleukin molecules
had been defined, isolated, characterized, and sequenced. Criti-
cal in this process were the development of new assays that were
amenable to quantitative analysis like the IL-2 bioassay. However,
despite this progress, none of the new interleukin molecules, either
alone or in combination, could effectively promote long-term B
cell proliferation and cloning as had been so successful using IL-2
to create T cell lines and clones. Accordingly, there seemed to be
something missing, or different about activation and proliferation
of B cells compared with T cells.
Looking back to “linked recognition” (95), the observation that
T cells contributed some vital physical signal to B cells indepen-
dently of soluble helper molecules had never been fully explained.
Thus, a report from Clark and Ledbetter of a MoAb that recog-
nized a 50 kDa (M r) surface molecule restricted to normal and
neoplastic B cells was of interest, in that this MoAb augmented
the proliferation of anti-IgM-activated human tonsil B cells (126).
This B cell surface molecule was subsequently given a classifica-
tion of CD40, and Blanchereau’s group then demonstrated the first
long-term growth of human B cell lines using IL-4 and anti-CD40
(127). Because it had been shown that resting T cells proliferate
to anti-CD3 bound to mouse fibroblastic cells expressing FcγRII,
several MoAbs reactive with various B cell surface molecules were
tested with these FcR+ cells for their capacity to activate the pro-
liferation of highly purified resting human B cells. Only MoAbs
reactive with CD40 induced proliferation. Particularly notewor-
thy, addition of recombinant IL-4 strongly enhanced the B cell
proliferation, whereas the addition of IL-2 only weakly enhanced
proliferation. B cells could be cultured with this combination for
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up to 10 weeks, and could be cloned by limiting dilution using the
anti-CD40 MoAb bound to the FcγRII-expressing cells+ IL-4.
Then within the span of a year, four groups reported finding
a surface molecule expressed by mitogen-activated Th cells that
bound to B cell CD40 and activated both their proliferation and
differentiation to AFCs. Lederman working in Chess’s group found
that a clone of the human T leukemia cell line JURKAT possessed
the unique capacity to induce the expression of B cell CD23. Using
this clone, a MoAb was generated that bound to the T cell clone
and inhibited activated T cells from inducing B cell CD23 expres-
sion (128, 129). Similarly, Spriggs’ group found that human CD40
bound to the murine thymoma cell line, EL4. Using an expres-
sion cDNA library constructed from EL4 mRNA and biotinylated
CD40, a cDNA was cloned that encoded a 260 amino acid residue
protein with a calculated M r= 29,395, which they termed CD40-
ligand (CD40-L). cDNA transfected paraformaldehyde-fixed cells
activated the proliferation of murine splenic B cells and the addi-
tion of IL-4 promoted their production of IgE. In addition, Noelle’s
group had already reported that paraformaldehyde-fixed mitogen-
activated Th cells and their purified plasma membranes induced B
cell cycle entry and that IL-4, but not IL-2, IL-5, or IFNγ, aug-
mented B cell DNA synthesis (130). Using a human CD40-Ig
fusion protein, they identified a 39 kDa surface molecule on acti-
vated but not resting Th cells, and raised a MoAb that reacted
with this protein that blocked the induction of B cell cycle entry
(131). Finally, two separate groups isolated human cDNA clones
encoding the human homolog of the murine CD40-L (132, 133).
The power of this molecular and genetic insight thus gained was
immediately realized by reports from three groups and a total of
10 individuals who suffered from X-linked Hyper-IgM syndrome,
which is a rare genetic disorder characterized by normal or ele-
vated levels of serum IgM but undetectable levels of IgG, IgA, and
IgE (134–136). Circulating B cell concentrations were normal, but
the cells exclusively expressed only surface IgM/IgD. Affected males
are unusually susceptible to recurrent pyogenic infections, autoim-
mune diseases, and lymphoproliferative diseases, thus a curious
paradoxical mixture of immunodeficiency and autoimmunity,
very similar to neonatal thymectomized mice (39). Genetic map-
ping of the CD40-L gene revealed that it is located in the q26.3-
q27.1 region of the X chromosome (132), while X-linked Hyper-
IgM syndrome had previously been assigned to Xq26. Various
genetic mutations in the 10 individuals accounted for either the
total lack of CD40-L expression, or to expression of CD40-L pro-
tein that failed to bind CD40. Accordingly, these reports solidified
the only non-redundant function of the CD40-L/CD40 interac-
tion is the important Ig class switch recombination that governs
the switch from theµ-constant region to the other constant region
H-chain isotypes.
CONCLUSION
In the decade after the discovery of the molecular nature of
the TCR complex and the realization that T cell effector mol-
ecules are antigen non-specific leukocytotrophic hormones, it
was possible to begin to identify, isolate, and characterize the
molecules responsible for adaptive immunity for the first time.
Thus, the biochemical analysis of antigen-specific TCR signaling
revealed that lymphocytes are excitable cells, not too different from
neuromuscular cells that react to their molecular environment by
signaling through their lipid membranes, leading to ion fluxes and
activation of phosphorylating enzyme cascades that regulate the
genetic expression of the cells. Among the first and most important
of the molecules encoded by the genes activated by the TCR were
the molecules involved in cytolysis and helper functions. The bio-
chemical understanding of apoptosis provided a molecular process
by which negative selection of immature lymphocytes reactive
with self-molecules provided a firm molecular underpinning of
Burnet’s prediction that self-reactive clones would be eliminated
during development. T cell clones and cloned TCR genes per-
mitted the generation transgenic animals that were instrumental
in demonstrating that the phenomena of negative and positive
selection actually occur. The molecular explanation of T cell help
of B cell proliferation and differentiation to AFCs, as residing
in both soluble interleukin molecules as well as cell surface lig-
and/receptor pairs, yielded a new understanding of how messages
are passed between the cells comprising the immune system. The
unraveling of the various new interleukin molecules involved in
T cell help was long and laborious but was ultimately successful
because of the use of cloned T cells and the creation of quanti-
tative bioassays, amenable to biochemical and genetic analysis of
the various activities. The initial results of these advances immedi-
ately became apparent in new understanding of genetic mutations
responsible for primary immunodeficiencies. Thus, the pathways
were opened to a further molecular delineation, dissection, and
elucidation of the TCR complex, the various interleukin receptors,
the biochemical signaling pathways, and genes activated by these
newly discovered adaptive immune molecules.
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